These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood. Amada N, Okazaki H, Sato T, Miura S, Ohashi Y. Transplant Proc; 2001 May; 33(3):2256-7. PubMed ID: 11377520 [No Abstract] [Full Text] [Related]
24. Effect of amino acid mismatch in the UNOS dataset. Sasaki N, El-Awar N, Idica A. Clin Transpl; 2011 May; ():299-309. PubMed ID: 22755423 [Abstract] [Full Text] [Related]
25. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009). Cai J. Clin Transpl; 2009 May; ():83-101. PubMed ID: 20524278 [Abstract] [Full Text] [Related]
30. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine. Kerman RH, van Buren CT, Lewis RM, Frazier OH, Cooley D, Kahan BD. Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425 [Abstract] [Full Text] [Related]
31. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants. Cecka JM. Clin Transpl; 1997 Feb; ():1-14. PubMed ID: 9919387 [Abstract] [Full Text] [Related]
33. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. Waki K, Sugawara Y, Mizuta K, Fujita H, Kadowaki T, Kokudo N. Clin Transpl; 2011 Feb; ():223-35. PubMed ID: 22755416 [Abstract] [Full Text] [Related]
35. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era. Marti HP, Henschkowski J, Laux G, Vogt B, Seiler C, Opelz G, Frey FJ. Transpl Int; 2006 Jan; 19(1):19-26. PubMed ID: 16359373 [Abstract] [Full Text] [Related]
36. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. Kuo HT, Huang E, Emami S, Pham PT, Wilkinson AH, Danovitch GM, Bunnapradist S. Transplantation; 2012 Mar 15; 93(5):493-502. PubMed ID: 22306574 [Abstract] [Full Text] [Related]
37. The effect of transfusions on renal allograft survival in the cyclosporine era: a single center report. Egidi MF, Scott DH, Corry RJ. Clin Transplant; 1993 Jun 15; 7(3):240-4. PubMed ID: 10148843 [Abstract] [Full Text] [Related]
38. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage. Tchervenkov JI, Cofer BR, Davies C, Alexander JW. Transplantation; 1995 Mar 27; 59(6):821-4. PubMed ID: 7701575 [Abstract] [Full Text] [Related]
39. Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant. Davies CB, Alexander JW, Cofer BR, First MR, Schroeder TJ. Ann Surg; 1992 Jun 27; 215(6):618-25; discussion 626. PubMed ID: 1632683 [Abstract] [Full Text] [Related]
40. Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys. Jonker M, van de Hout Y, Neuhaus P, Ringers J, Kuhn EM, Bruijn JA, Noort R, Doxiadis G, Otting N, Bontrop RE, Claas FH, van Rood JJ. Transplantation; 1998 Oct 15; 66(7):925-7. PubMed ID: 9798705 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]